# Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema

> **NCT00874744** · PHASE2 · COMPLETED · sponsor: **Universidade Federal de Goias** · enrollment: 13 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Triamcinolone acetonide

## Key facts

- **NCT ID:** NCT00874744
- **Lead sponsor:** Universidade Federal de Goias
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-09
- **Final completion:** 2008-10
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2009-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00874744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00874744, "Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00874744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*